Help | RSS Feed

Interpace Diagnostics Group, Inc. (NASD:IDXG) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Interpace Diagnostics Group, Inc. (NASD:IDXG) seasonal charts above shows that a Buy Date of April 3 and a Sell Date of July 23 has resulted in a geometric average return of 3.59% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 15 of those periods. This is a good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 40.49% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Interpace Biosciences Inc is a growing leader in the life sciences industry. It provides complex molecular analysis for the early diagnosis and treatment of cancer and supporting the development of targeted therapeutics. The activities of the company are functioned through two business units. The Interpace Diagnostics business unit which provides evidence-based, clinically beneficial molecular diagnostic tests and pathology services and Interpace Pharma Solutions business supports clinical trials by providing lab testing, data management, project management, and biorepository services to biopharmaceutical companies.

To download IDXG seasonal chart data, please log in or Subscribe.


Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z